Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2005-11-30
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal Women
NCT04836637
Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female
NCT05434806
The Effect of Vitamin D on Bone Accretion and Turn-Over in Young Girls
NCT00267540
Effect of Vitamin d and Omega 3 on Osteocalcin
NCT04005612
Pharmacokinetics of Calcifediol and Cholecalciferol
NCT02333682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Up till now little attention has been given the exploitation of marine by-products from the fishing industry. Calcium in fish is found mainly in bone and skin. By-products from these sources are limited to production of gelatine. Small fish, which can be eaten whole with bones included, are traditionally considered to be a good source of calcium. Until recently, bioavailability of this calcium was not known. Two recent studies from Denmark have shown that the absorption of calcium from small soft-boned fish was comparable to that of skimmed milk both in rats and in humans.
Calcium fortified foods are likely to play an important role in helping consumers to achieve calcium requirements aimed at reducing the risk of developing osteoporosis. Experimental evidence show a positive effect of calcium supplementation on bone mineral accretion in children, and combined calcium and vitamin D supplementation has resulted in reduced bone loss and fracture incidence in older men and women.
This protocol describes a project on the nutritional utilisation of calcium from fish bone waste. The main objective is to maximise the use and the added value of marine by-products with special emphasis on utilisation of fish bone as a calcium source and determine its bioavailabiliy in humans.
Study design :
This study will follow a 3x7 weeks ransomised crossover design, where the calcium absorption and retention will be measured form meals labelled with 47Ca. The test meals will be digested in the morning after a 12h fast and bloodsampling. Whole body retention will be measured on day 15, 22 and 26, and calibrated against a background measurement from the day prior to ingestion of the test meal. The subjects will receive an ordinary standardised diet for 2 days prior and 3 days after the test meals. This diet will be standardised to match the subjects' individual calcium intake.
Test meals:
Two types of fish bone meal (from salmon and cod fish) and a control (CaCO3) will be tested. Amounts equivalent of 800 mg Ca will be baked into bread, which will be labelled with 47Ca and served with 500 mL of ultra pure water at the department.
Isotopes and labelling procedure:
Isotopes (47Ca) will be ordered from Risø National Laboratory, Radiation Research Department, Denmark. The department of Human Nutrition will recieve the prepared doses of isotopes the day before the test meal. A dose of 0.2 MBq/ml will be used. The doses will be used to extrinsically label the test meals by drop-wise adding 1 ml of isotope solution in the afternoon on the day before intake of test meals and stored at 5 degree C until ingested.
Since each subject will recieve labelled meals on three occasions, a total dose of 0.6 MBq will be ingested during the study.
Measurement of calcium retention:
The whole body retention of calcium will be measured with a whole body counter at the Copenhagen University Hospital, Denmark. All measurements of calcium retention will be corrected for physical decay back to the time of administration.
Chemical analyses:
Serun calcium, phosphorus and vitamin D concentrations will be determined in before each test meal. Plasma levels of PTH will be determined before the first test meal only.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calcium controlled diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI: 18-18 kg/m2
* age: 18-40 years
Exclusion Criteria
* on medication
* gastrointestinal disorders, chronic diseaes
* smoking
* prior participation in radioisotpe studies
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nutrition and Seafood Research, Norway
OTHER_GOV
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arne Astrup
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanne Bügel, MSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Human Nutrition, THe Royal Veterinary and Agricultural University, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Human Nutirtion, The Royal Veterinary and Agricultural University, Denmark
Frederiksberg, Frederiksberg C, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M182
Identifier Type: -
Identifier Source: secondary_id
KF-01270319
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.